Introduction
============

Reactive oxygen species (ROS) have long been viewed as purely harmful molecules contributing to oxidative stress, which can cause severe cell damage. On the other hand, ROS can also play a beneficial role, for example in intracellular signaling and innate immune defense. Intracellular bacteria of the genus *Wolbachia* have evolved intriguing capabilities to manipulate the biology of their arthropod hosts. *Wolbachia* have recently been shown to influence ROS production and the oxidative environment as a whole, suggesting an involvement of ROS in *Wolbachia*-induced phenotypes. In this article, we briefly review the relevant facts about ROS and give an overview of the insect immune response with a focus on ROS. In the main part, we outline the interactions between *Wolbachia* and the host immune system. We explore the possible roles of ROS in different *Wolbachia* phenotypes and hypothesize how interference with the host oxidative environment has shaped various aspects of the *Wolbachia-*insect symbiosis. Finally, we discuss some corollaries of the hypothesis.

Reactive Oxygen Species, Oxidative Stress, and Redox Homeostasis
================================================================

After the advent of molecular oxygen in the Earth's atmosphere, organisms evolved metabolic mechanisms that use oxygen to produce energy. In eukaryotic cells, aerobic respiration takes place in the mitochondria. During oxidative phosphorylation, electrons are transferred along the mitochondrial respiratory chain to generate a proton gradient which eventually enables the synthesis of ATP. In this electron transport chain, the final acceptor of electrons is molecular oxygen which thereby is reduced to produce water. Occasionally, however, oxygen is prematurely and incompletely reduced, giving rise to superoxide. The superoxide anion belongs to a class of oxygen-derived molecules that readily oxidize other molecules and are commonly referred to as ROS. In addition to superoxide, ROS include hydrogen peroxide, hypochlorous acid, hydroxyl radical, singlet oxygen, and ozon. It has been known for a long time that an excessive load of ROS damages diverse cellular macromolecules, including proteins, lipids, and DNA, a process known as oxidative stress. The concept of oxidative stress has its roots in the mid-twentieth century when researchers began to explore the harmful effects of oxidizing free radicals ([@B58]) and their possible involvement in the aging process ([@B68]). A couple of years later, the antioxidant enzyme superoxide dismutase (SOD) was discovered which eliminates superoxide from the cell and thus protects the cell from its toxicity ([@B127]; [@B128]). Antioxidant enzymes aimed at detoxifying hydrogen peroxide include glutathione peroxidase (GPx), thioredoxin peroxidase (TPx), which is a member of the Peroxiredoxin (Prx) family, and catalase. Since the discovery of antioxidants, oxidative stress has been invoked as contributing to a number of diseases, including cancer ([@B193]; [@B200]), cardiovascular diseases ([@B62]), neurodegenerative disorders ([@B8]), and diabetes ([@B121]). Oxidative stress also negatively affects male and female reproductive ability, and detoxification of ROS by antioxidants is required for maintaining fertility/fecundity in *Drosophila* ([@B154]), mosquitoes ([@B37]), and mammals ([@B74]). In general, therefore, ROS have long been seen as harmful but unavoidable by-products of an aerobic lifestyle.

It therefore came as a surprise when enzymes were discovered whose sole function is the production of ROS ([@B170]; [@B197]). The membrane-bound enzymes NADPH oxidases (NOX1-5) and dual oxidases (DUOX1--2) catalyze the reduction of molecular oxygen to generate superoxide and/or hydrogen peroxide, using NADPH as an electron donor ([@B19]). DUOX enzymes can be distinguished from NOX enzymes by the presence of an extracellular peroxidase homology domain (PHD), in addition to the intracellular NADPH oxidase domain ([@B104]). Commonly, however, the term NOX is used for the whole seven-member protein family. NOX enzymes are expressed in a diverse array of cells and tissues and are present in most eukaryotes ([@B9]; [@B1]). Therefore, the view that ROS are purely harmful by-products of mitochondrial metabolism needed reconsideration. It is important to note, though, that despite the existence of ROS-producing enzymes, the vast majority of cellular ROS (estimated at approximately 90%) can be traced back to a mitochondrial origin ([@B4]). Nevertheless, the fact that ROS are actively synthesized prompted research into their possible biological functions. It is now clear that ROS, both those produced within mitochondria and those generated by NOX enzymes, act as important signaling molecules in diverse physiological processes. As such, ROS are involved in regulating cellular homeostasis, stem cell proliferation and differentiation, cell motility and migration, autophagy, cell death and aging, and, last but not least, immunity and host defense ([@B35]; [@B67]; [@B52]; [@B164]; [@B184]; [@B145]; [@B75]; [@B105]; [@B179]; [@B165]). Therefore, organisms must tightly control the balance between ROS production and degradation. This fine-tuned balance between oxidants and antioxidants is called redox homeostasis.

Insect Immunity: Antimicrobial Peptides, ROS, and Autophagy
===========================================================

The innate immune response of insects consists of multiple defense mechanisms, including epithelial barriers and both local and systemic immune reactions. Most research in insect immunity has focused on *Drosophila melanogaster* ([@B113]; [@B21]; but see [@B168], for a broader perspective). The cellular immune response is executed by hemocytes and emcompasses several distinct mechanisms, including phagocytosis, encapsulation, coagulation, and melanization ([@B87]; [@B113]; [@B195]; [@B49]). Some of these mechanisms (encapsulation, melanization) involve the generation of ROS at infection sites to kill pathogens ([@B144]; [@B142]; [@B100]). At the core of the systemic immune response lies the production of antimicrobial peptides (AMPs) by the fat body and their subsequent release into the hemolymph (for an overview of insect AMPs, see [@B216]). AMP gene expression is mainly controlled by two distinct signaling pathways, the Toll pathway and the Imd pathway, both of which include homologs of the NF-κB pathway ([@B93]; [@B16]; [@B50]; [@B113]; [@B72]). The Imd pathway is predominantly activated by Gram-negative bacteria, whereas Gram-positive bacteria, fungi, and yeast trigger the Toll pathway ([@B21]). In the lab, systemic responses have frequently been elicited by bacterial injection into the hemocoel. However, this might not reflect the natural way of infection. Commonly, epithelia such as those lining the gut are the first barrier a pathogen encounters when infecting the host. A peculiarity of gut epithelia is the fact that they not only are in constant contact with pathogens, but also host a number of beneficial commensal bacteria, the so-called gut microbiota. Commensal gut microbes are involved in diverse physiological functions of their hosts, including organ development and morphogenesis, host metabolism, and immunity ([@B188]; for reviews on the *Drosophila*/insect gut microbiota, see, for example, [@B20]; [@B46]; [@B47]; [@B112]). The challenge for the host immune system, therefore, is to find the balance between fighting pathogens and tolerating the microbiota ([@B177]).

Accordingly, a tight regulation of the production of immune effector molecules is strictly needed. In the *Drosophila* gut, there are two major classes of immune effectors, AMPs and ROS ([@B173]; [@B101]). AMP generation in the gut is controlled by the Imd pathway, but not by the Toll pathway ([@B199]). The Imd pathway is triggered when the bacterial cell wall component diaminopimelic acid (DAP)-type peptidoglycan (PG) is recognized by PG recognition proteins (PGRPs) in the host membrane ([@B114]; [@B14]; [@B146]; for reviews on PGRPs, see [@B171]; [@B172]). In the absence of pathogenic bacteria, PG-triggered AMP gene expression is repressed by negative regulators of the Imd pathway to protect the commensal microbiota, thereby maintaining the balance between immune tolerance and immune response ([@B115]; [@B175]; [@B153]; [@B14]; [@B13]; [@B34]).

Local production of AMPs only seems to constitute a complementary response against microbes that are resistant against ROS ([@B174]), the second major immune effector class in the *Drosophila* gut. Indeed, DUOX-dependent production of microbicidal ROS serves as the first line of defense in gut immunity ([@B65], [@B63]). It is assumed that the NADPH oxidase domain of DUOX synthesizes H~2~O~2~, which the PHD then converts into the highly microbicidal HOCl in the presence of chloride ([@B65]). Infection-induced ROS generation in the *Drosophila* gut can also act as a signal for AMP production in the fat body, thus triggering a systemic immune response ([@B212]). After the pathogen-induced increase in ROS production, ROS levels are actively reduced by immune-regulated catalase (IRC) activity to avoid excessive oxidative stress ([@B66]).

DUOX-dependent ROS production in the *Drosophila* gut is regulated by two signaling pathways ([@B3]): The enzymatic activity of DUOX is controlled by the Gαq-PLCβ-Ca^2+^ pathway ("DUOX activity pathway"; [@B63]), while DUOX gene expression is regulated by a MEKK1-MKK3-p38-ATF2 pathway ("DUOX expression pathway"; [@B64], [@B26]). Activation of both pathways is required for stable ROS production. Interestingly, PG is able to activate the DUOX expression pathway, but not the DUOX activity pathway. Therefore, DUOX-dependent ROS generation cannot depend on PG alone ([@B63],[@B64]; [@B3]). Recently, bacterial-derived uracil was identified as a non-PG ligand triggering DUOX-dependent ROS generation ([@B111]). Uracil is probably recognized by a G-protein-coupled receptor (GPCR) and, via Hedgehog-induced signaling endosomes, induces PLCβ-dependent Ca^2+^ mobilization which triggers DUOX activation ([@B110]). Strikingly, uracil is released by pathogenic bacteria, but not by commensal symbionts ([@B111]). This allows the gut epithelia to distinguish between pathogens and commensal bacteria, thus maintaining immune homeostasis in the *Drosophila* gut ([@B94]; [@B217]).

What do we know about the involvement of ROS in innate immunity and host defense in insects other than *Drosophila*? The production of ROS as a countermeasure to bacterial and/or fungal infection has been reported from species as diverse as the cockroach *Blaberus discoidalis* (Blattodea; [@B209]), the silkworm *Bombyx mori* (Lepidoptera; [@B85]), the scale insect *Dactylopius coccus* (Hemiptera; [@B56]), the greater wax moth *Galleria mellonella* (Lepidoptera; [@B10]), the sand fly *Lutzomyia longipalpis* (Diptera; [@B40]), the tiger moth *Parasemia plantaginis* (Lepidoptera; [@B133]), and the cattle tick *Rhipicephalus microplus* (Ixodida; [@B157]). Hematophagous insects may also become infected by blood--borne parasites, e.g., the malaria parasite *Plasmodium*. The mosquito *Anopheles gambiae* is one of the most efficient malaria vectors known. Interestingly, sufficiently high ROS levels are required for *An. gambiae* to mount an effective immune response against *Plasmodium* and bacteria ([@B100]; [@B134]). Elevated ROS levels to fight off *Plasmodium* can be generated by mitochondria in mosquito midgut cells ([@B60]) or by an *Enterobacter* bacterium from the *An. gambiae* gut microbiota ([@B33]). Therefore, host defense against bacterial, fungal, and *Plasmodium* infection based on ROS is widespread among various insect species.

Insect immunity based on the production of AMPs and ROS (controlled by the Toll pathway, the Imd pathway, and both DUOX pathways) is able to fight off both Gram-positive and Gram-negative bacteria, fungi, yeast, and protozoa such as *Plasmodium* ([@B24]; [@B21]). AMP production based on the Toll/Imd pathways may also be involved in the antiviral response, in addition to RNA interference and other mechanisms ([@B214]; [@B176]; [@B130]; [@B51]; [@B106]). To the best of our knowledge, however, nothing is known about ROS as antiviral effectors in a natural insect system (but see [@B205], and below). In general, insect host defenses against intracellular pathogens (such as viruses) are less well studied than those against extracellular pathogens. AMPs have been shown to control obligate intracellular bacteria such as *Rickettsia* and *Anaplasma* ([@B5]; [@B117]). Moreover, several immune responses are known that specifically target intracellular pathogens ([@B192]; [@B120]; [@B156]). Autophagy seems to represent a general and evolutionarily conserved defense mechanism against intracellular pathogens ([@B201]; [@B38]; [@B141]; [@B218]; [@B30]; [@B39]). In *Drosophila*, for example, one type of PGRP (PGRP-LE) acts as an intracellular receptor for DAP-type PG and thus as an intracellular sensor of Gram-negative bacteria ([@B91]). PGRP-LE also induces an autophagic response to prevent the intracellular growth of bacterial pathogens, and this induction occurs independently of the Toll and Imd pathways ([@B215]; [@B102]). Moreover, autophagy is also activated and regulated by ROS ([@B77]; [@B178]; [@B184]). In sum, several distinct and yet interconnected immune responses are at work to defend the insect host against a plethora of different pathogens.

*Wolbachia* and the Insect Immune System
========================================

*Wolbachia* are maternally transmitted intracellular Gram-negative bacteria that infect a vast range of arthropod species, probably making them the most prevalent endosymbionts in the world ([@B73]; [@B225]; [@B207]). *Wolbachia*'s evolutionary success is generally attributed to their reproductive parasitism, which ensures their vertical transmission from mother to offspring ([@B194]; [@B208]). These reproductive manipulations include male killing, feminization, parthenogenesis induction, and cytoplasmic incompatibility (CI). The latter phenotype seems to be the most frequent one and occurs if males infected with CI-*Wolbachia* mate with uninfected females; these matings suffer from high offspring mortality. Infected females, in contrast, can mate successfully with both uninfected and infected males. In sum, all reproductive manipulations enhance the proportion of infected females and thus benefit the maternally inherited *Wolbachia*. Recently, however, two additional facets of the biology of *Wolbachia* are increasingly acknowledged to contribute to their success: horizontal transmission and mutualistic effects. Transmission between different host species is likely to be a major reason for *Wolbachia*'s vast abundance, particularly if it occurs over large phylogenetic distances ([@B227]). In addition, the global spread of *Wolbachia* might be facilitated by mutualistic effects such as increased host fecundity and longevity or protection against pathogens ([@B226]). Nevertheless, reproductive parasitism seems to be more prevalent than mutualism in arthropod hosts, and it is frequently associated with a fitness cost to the host ([@B226]).

What does the host defense against *Wolbachia* infection look like? In principle, hosts can employ two different strategies to defend themselves against infections: resistance and tolerance. Resistance is the ability to clear the infection, while tolerance is the ability to reduce the fitness costs of infection, without clearing the infection itself ([@B181]). Whether a host responds to *Wolbachia* through resistance or tolerance strongly depends on two features of the infection: its age and its phenotypic effects. A recently acquired infection is likely to trigger an immune response, which is the key resistance mechanism. In coevolved associations, by contrast, resistance may no longer be the best response to infection. Whether or not resistance is the host's best option in coevolved symbioses mainly depends on the symbiont's phenotype. Reproductive manipulations such as feminization and male killing reduce host fitness and thus are expected to lead to the evolution of resistance. Indeed, host suppressor alleles have been identified that confer resistance to feminizing and male killing *Wolbachia* ([@B166]; [@B76]). With other *Wolbachia* phenotypes, things are a bit more complex. In the case of CI, infected females are "addicted" to *Wolbachia*---if they lose the symbionts, their offspring will suffer from high mortality rates when fathered by infected males. Therefore, females infected with CI-*Wolbachia* are selected to maintain the bacteria and even increase the efficiency of maternal transmission. On the other hand, suppressor genes are predicted to spread in males, and successive selection for male suppressors of *Wolbachia* should lead to long-term elimination of infection ([@B96]). With respect to *Wolbachia*-induced parthenogenesis, the symbiont has gone to fixation in most populations that are infected. In these populations there are no males, and females depend on the bacteria for asexual reproduction. Under such circumstances of host dependence, infected females are not expected to evolve mechanisms of resistance ("dependence" barrier to resistance; [@B226]). However, nuclear suppressor alleles have been hypothesized for populations where infected and uninfected individuals coexist ([@B79]). Finally, if *Wolbachia* exhibits a mutualistic phenotype, evolution of resistance will also be selected against ("fitness benefit" barrier to resistance; [@B226]). When resistance is not feasible, tolerance mechanisms represent an alternative host strategy to deal with the infection. The evolution of tolerance is associated with the attenuation of the immune response that originally was there to eliminate the bacteria. Immune tolerance is also an efficient means to reduce the risk that host tissue is damaged as a side effect of the immune response (immunopathology).

In summary, the evolution of host resistance is expected in many, but not all, *Wolbachia*--host associations. In those associations in which resistance evolution is expected, *Wolbachia* should, in principle, trigger the host immune system which should aim at eliminating the bacteria, regardless of whether they are novel or native. On the other hand, given the huge number of infected insect species and the recurrent occurrence of successful transmission into novel host species, why is the host defense machinery not more efficient in overcoming the infection? Have *Wolbachia* evolved mechanisms to suppress or interfere with the immune system, or do they hide from it? Or does the high prevalence of *Wolbachia* indicate that, frequently, hosts are not selected to evolve resistance (but rather tolerance)? In the following paragraphs, we outline in more detail the interplay between *Wolbachia* infection and the different host defense mechanisms, with special emphasis on the host oxidative environment.

*Wolbachia* and AMP-/Autophagy-Based Immunity
---------------------------------------------

Interestingly, in their native hosts, *Wolbachia* do not induce AMP gene expression, as has been shown for *Aedes albopictus*, *D. melanogaster*, *Drosophila simulans*, and *Tetranychus urticae* ([@B15]; [@B211]; [@B163]; [@B223]). On the other hand, *Wolbachia*-infected *D. simulans* and *Ae. albopictus* are still able to activate AMP gene expression when challenged by other bacterial pathogens, e.g., *E. coli* ([@B15]). These results suggest that *Wolbachia* neither induce nor suppress the AMP-based branch of the immune system of their natural hosts. *Drosophila* species seem to be naturally infected with only two maternally inherited bacteria, *Wolbachia* and *Spiroplasma* ([@B125]). In *Spiroplasma*-infected *D. melanogaster*, the same picture emerges: in their natural host, the bacteria neither upregulate nor downregulate the expression of AMP genes ([@B80]; [@B82]). Taken together, these findings suggest that endosymbionts such as *Wolbachia* have evolved means to evade the host immune system by stealth (Figure [1D](#F1){ref-type="fig"}; [@B187]). This notion is corroborated by the fact that, in the host cytoplasm, *Wolbachia* are located within vesicles whose outermost membrane is of host origin ([@B119]). This probably helps the bacteria to hide from the host immune system. Another possible reason for the lack of *Wolbachia*-induced AMP upregulation is that the host has shut down the AMP-based immune response when selection favors the maintenance of the bacteria (Figure [1G](#F1){ref-type="fig"}). However, it is unclear how this immune tolerance could be restricted to *Wolbachia* so that other pathogens are still effectively targeted. This problem could be resolved by the fact that AMPs do not need to be shut down for ensuring immune tolerance in coevolved symbioses, but instead are actively involved in symbiont maintenance ([@B118]).

![**Hypothesized effects of ***Wolbachia*** on the immune system of novel (A--C) and coevolved hosts (D--I).** Newly introduced *Wolbachia* (red dots) trigger an immune response by upregulating the expression of several immune effectors such as AMPs **(A)**, autophagy-related proteins **(B)**, and ROS **(C)**. A ROS-based immune response leads to oxidative stress. Due to host-symbiont coevolution, native *Wolbachia* (green dots) have ceased triggering an immune response. They neither induce nor suppress AMP expression, but evade the AMP-based immune response by stealth **(D)**. Presumably, they downregulate autophagy-related genes **(E)**. With regard to the ROS-based branch of the immune system, we hypothesize that *Wolbachia* not only induce ROS production and oxidative stress, but also the expression of antioxidant genes. By such immune interference, *Wolbachia* restore redox homeostasis **(F)**. Another coevolutionary outcome is host-driven shutdown of the immune response (immune tolerance; **G--I**). By evolving ROS-associated immune tolerance, the host restores redox homeostasis itself **(I)**. Note that evolution of resistance is also a possible outcome of coevolution, but eventually leads to symbiosis breakdown and therefore is not depicted here.](fmicb-06-01201-g0001){#F1}

The fact that *Wolbachia* do not elicit an AMP-based immune response in their native hosts stands in stark contrast to the strong induction of AMP gene expression when *Wolbachia* are introduced into novel hosts (Figure [1A](#F1){ref-type="fig"}; [@B213]; [@B90], [@B89]; [@B138]; [@B12]). This is indicative of a systemic immune response triggered by the canonical Toll and/or Imd pathway (immune upregulation; note that the term immune priming is equivalent to such general immune upregulation only in its unspecific meaning; compare, for example, [@B169] and [@B124] for a different usage of the term). As Gram-negative bacteria, newly introduced *Wolbachia* are probably detected by the Imd pathway that is triggered by recognition of DAP-type PG from the bacterial cell wall. Although *Wolbachia* lack a proper cell wall and PG has never been detected, they are probably able to synthesize DAP ([@B45]; [@B202]). Moreover, it was recently shown that the PG-associated lipoprotein (PAL) is located on the cell membrane of *Wolbachia* ([@B204]). PAL is known to specifically bind DAP ([@B155]). Therefore, DAP is present on the *Wolbachia* membrane, and perhaps this is sufficient to be recognized by PGRPs which then trigger the Imd pathway and subsequent AMP generation.

The discovery of PGRP-LE as an intracellular sensor of DAP-type PG ([@B91]) also opens the possibility of an autophagic immune defense against *Wolbachia*. It was recently shown that *Wolbachia* induce the autophagy pathway in a naturally infected *Ae. albopictus* cell line ([@B203]). Hence, one might expect bacterial strategies to counteract autophagy. Indeed, autophagy-associated genes are downregulated in the ovaries of two hosts naturally infected with *Wolbachia*, the woodlouse *Armadillidium vulgare* and the wasp *Asobara tabida*, supporting the notion that the symbionts suppress the autophagic signal to prevent their elimination (Figure [1E](#F1){ref-type="fig"}; [@B29]; [@B97]). Again, it is also conceivable that the host itself is responsible for the downregulation---another possible case of evolved immune tolerance when symbiont presence is favored (Figure [1H](#F1){ref-type="fig"}). In contrast to these coevolved associations, a transfected *Wolbachia* strain causes a catastrophic autophagic response in another woodlouse, *Porcellio d. dilatatus*, resulting in the death of the new host (Figure [1B](#F1){ref-type="fig"}; [@B109]). Therefore, an autophagic immune response is observable in novel, but not in native hosts, mirroring the situation with regard to AMP-based immune defense.

How can we reconcile these differing findings concerning the immune response to *Wolbachia* in native vs. novel hosts? Perhaps, it is not too surprising that *Wolbachia* do elicit an immune response in novel hosts. In insects that acquired *Wolbachia* only recently (either by natural or artificial means), the bacteria are recognized as foreign, probably by PGRPs detecting DAP on *Wolbachia* membranes, and then AMP- and/or autophagy-associated defense mechanisms are triggered to eliminate the infection (Figures [1A](#F1){ref-type="fig"},[B](#F1){ref-type="fig"}). With ongoing coevolution, however, *Wolbachia* have found ways to prevent their elimination, for example by evading the AMP-based immune response (immune evasion by stealth; Figure [1D](#F1){ref-type="fig"}) and by suppressing the autophagy-associated immune defense (immune suppression; Figure [1E](#F1){ref-type="fig"}). Alternatively, evolution of immune tolerance enables the host to reduce costly defense mechanisms when selection favors the presence of *Wolbachia* (Figures [1G](#F1){ref-type="fig"},[H](#F1){ref-type="fig"}).

*Wolbachia* and ROS-Based Immunity
----------------------------------

Given their vertical transmission through the female germline and their reproductive manipulations, *Wolbachia* are expected to reside primarily in the host reproductive tissues. Although this is true, they are also able to infect somatic tissues, including tissues of immunological importance, such as the gut, fat body, and hemolymph ([@B42]; [@B28]; [@B83]; [@B224]; [@B55]). In gut epithelia, AMPs represent only one of two major classes of immune effectors, the other one being ROS (see above). Therefore, when asking about the relationship between *Wolbachia* infection and the host immune system, it is also important to consider possible interactions between *Wolbachia* on the one hand and ROS and the oxidative environment on the other hand, in particular if infection in the gut has been reported.

The first, indirect evidence of such an interaction between *Wolbachia* and the host oxidative environment came from studies on the role of mitochondria in various aspects of host biology. In *D. melanogaster*, tetracycline treatment to eliminate *Wolbachia* resulted in a significant decrease in lipid hydroperoxide, a marker for ROS-induced oxidative damage ([@B44]). However, this finding could be due to a direct negative effect of tetracycline on mitochondrial efficiency ([@B7]). Further indirect evidence comes from the fact that *Wolbachia* infection can have a profound influence on mitochondrial DNA (mtDNA) haplotype diversity ([@B81]), and different mtDNA haplotypes can differ in mitochondrial ROS production rates ([@B6]).

[@B18] were the first to demonstrate a more direct effect of *Wolbachia* on the host oxidative environment. The mosquito *Ae. albopictus* is naturally infected with CI-inducing *Wolbachia*. In an *Ae. albopictus* cell line, the authors found that *Wolbachia* infection is associated with high levels of ROS (as compared to an identical cell line treated with the antibiotic rifampicin). These ROS probably are a product of the host immune response (although they may also be a side-product of bacterial metabolism). In addition, *Wolbachia* infection is associated with the upregulation of several host antioxidant genes. These antioxidant proteins include copper-zinc SOD1, Prx5, and GPx. Antioxidant upregulation may be a host countermeasure to mitigate the negative effects of increased ROS levels. However, as the authors point out, there is so far only little support in the literature for antioxidant upregulation as a host response to pathogen infection. Alternatively, one might speculate that *Wolbachia* induce the host antioxidant system in order to be protected against the host immune response based on increased ROS levels. Possibly, induction of the host antioxidant system is due to effectors secreted by the bacterial type IV secretion system (T4SS). The *Wolbachia* T4SS is a potential pathway to transfer effector proteins into the host cytoplasm and therefore might be involved in *Wolbachia*-induced host phenotypes ([@B158]). Recently, a T4SS effector in *Ehrlichia* (a close relative of *Wolbachia*) was shown to be translocated to mitochondria and to upregulate a host SOD (MnSOD), thereby reducing ROS levels and apoptosis ([@B116]). Lastly, *Wolbachia* also seem to be able to produce their own antioxidants to protect themselves, since two bacterial antioxidant proteins were identified as well, a bacterial type of SOD (Fe-SOD) and bacterioferritin (Bfr). Iron (Fe) is an essential element for most organisms, but also a cause of oxidative stress as it catalyzes the generation of highly reactive hydroxyl radicals (Fenton reaction; [@B143]). Hence, bacterioferritin has important functions both in bacterial iron storage and, although not commonly referred to as an antioxidant, in fighting iron-mediated oxidative stress ([@B23]). Upregulation of *Wolbachia* bacterioferritin expression under iron-induced stress was also observed in naturally infected *D. simulans* ([@B99]). Given the crucial role of iron at the interface of immunity, infection and host--pathogen interactions ([@B25]; [@B140]), *Wolbachia*'s ability to interfere with host iron metabolism might be an important factor underlying diverse phenotypes and thus contributing to the unparalleled success of *Wolbachia* ([@B59]).

### *Wolbachia* and the Oxidative Environment: A Hypothesis

Based on the results by [@B18], on subsequent propositions regarding the possible involvement of *Wolbachia* in the host oxidative environment ([@B98]; [@B137]), and on the findings concerning AMP-/autophagy-based immunity, we propose the following hypothesis. In novel hosts, *Wolbachia* induce a ROS-based immune response, leading to oxidative stress (Figure [1C](#F1){ref-type="fig"}). In general, therefore, we expect infections in novel hosts to be associated with a disruption of redox homeostasis (although *Wolbachia* effects on antioxidant production are hardly predictable). In native hosts, by contrast, *Wolbachia* infection is expected to be associated with restored redox homeostasis, resulting from coevolutionary processes between symbiont and host. Redox homeostasis can be restored by *Wolbachia* or by the host (or by a combination of both) because both benefit from reduced oxidative stress. In the first case, *Wolbachia* not only induce a ROS-based immune response, but also the expression of antioxidant genes (regardless of whether these genes are part of the symbiont or host genome). In doing so, the bacteria interfere with the host immune response (immune interference) and are involved in maintaining redox homeostasis (Figure [1F](#F1){ref-type="fig"}). This may be particularly relevant if there are additional sources of oxidative stress (e.g., iron overload). In the second case, the host decreases the *Wolbachia*-induced immune response by reducing ROS production or by increasing antioxidant production (immune tolerance), and thereby restores redox homeostasis itself (Figure [1I](#F1){ref-type="fig"}). In what follows, we will gather further evidence in support of this hypothesis.

### *Wolbachia* and the Oxidative Environment in Novel Hosts

Several studies report effects of *Wolbachia* infection on the oxidative environment of arthropods that are naturally either uninfected of infected with a different strain. Examples where a novel *Wolbachia* infection causes an increase in ROS levels include the mosquitoes *Aedes aegypti* ([@B151]), *Aedes polynesiensis* ([@B2]), and *Anopheles stephensi* ([@B11]). All mosquitoes were transfected with the *Wolbachia* strain *w*AlbB, which naturally infects *Ae. albopictus*. In *Ae. aegypti*, ROS production was shown to be due to the upregulation of NADPH oxidase (NOXM) and dual oxidase (DUOX2), the latter one being upregulated 28-fold ([@B151]). Interestingly, the authors found that increased ROS levels activate the Toll pathway, leading to the production of AMPs and antioxidants. The fact that *Wolbachia* induce both the activation of ROS and antioxidants in *Ae. aegypti* is reminiscent of the situation in evolved symbioses (immune interference by *Wolbachia*). Given the relatively close phylogenetic relationship between donor (*Ae. albopictus*) and recipient (*Ae. aegypti*), it might not be too difficult for *w*AlbB to induce antioxidant production in *Ae. aegypti* and thus establish redox homeostasis in a novel host. On the other hand, some studies involving transfected cell lines show the downregulation of antioxidants as a result of infection ([@B213]; [@B78]). In sum, there is good evidence of the induction of ROS production by *Wolbachia* in novel hosts, whereas findings on the effects of novel infections on antioxidant production are so far inconclusive.

### *Wolbachia* and the Oxidative Environment in Native Hosts

In addition to the results by [@B18] in an *Ae. albopictus* cell line, there is also evidence in support of our hypothesis that comes from whole insects. Using different methods, [@B135] re-examined the production of ROS and antioxidants in *Ae. albopictus*, both in mosquito and cell lines. Interestingly, they did not find any significant difference in infected vs. uninfected lines, a finding that differs from that by [@B18]. Nevertheless, it can similarly be interpreted as an outcome of host-symbiont coevolution, i.e., as attenuation of the immune response to *Wolbachia* in its natural host (immune tolerance). Thus, although it is unclear why both studies come to different results at the molecular level, the conclusion that can be drawn from them is the same: coevolution between *Ae. albopictus* and its *Wolbachia* has led to restored redox homeostasis, either through immune interference (suggested by the results from [@B18]) or immune tolerance (suggested by [@B135]).

In *D. simulans* naturally infected with *Wolbachia*, total ROS levels are significantly higher in infected males than in males cured of infection. Moreover, DUOX is located in close proximity to the *Wolbachia*-containing vesicles ([@B70]). This suggests that the host recognizes *Wolbachia* as foreign and prompts an immune response involving DUOX-dependent ROS production. On the other hand, total SOD levels (including two host SODs and bacterial Fe-SOD) are also significantly higher in infected flies than in uninfected flies ([@B17]). These findings suggest that *Wolbachia* infection in the natural host *D. simulans* induces not only a host immune response, but also antioxidant production.

As already mentioned, the ability of *Wolbachia* to interfere with the host oxidative environment might be of particular importance if the level of oxidative stress is elevated by external factors. Toxicity of the heavy metal lead is mainly attributed to its ability to generate ROS and to impair the antioxidant defense ([@B53]). When *D. melanogaster* is challenged by a lead-contaminated diet, flies cured of infection exhibit a strongly increased malondialdehyde content, which is a marker for oxidative stress. In addition, high-lead diet significantly decreases SOD activity in cured flies, but not in infected flies ([@B206]).

Another example of the putative role of *Wolbachia* in maintaining redox homeostasis under stressful conditions involves the oxidative challenge imposed by blood-feeding. Ingestion of a blood meal is associated with the release of large amounts of the iron-containing cofactor heme in the gut. When not bound to proteins, heme has potential pro-oxidant and cytotoxic effects in that it converts weakly ROS into highly reactive ones ([@B86]). Hematophagous insects have evolved different mechanisms to be protected from these cytotoxic effects, including the binding, aggregation, and degradation of heme, and expression of antioxidant enzymes ([@B148]; [@B61]; [@B150]). Maintenance of redox homeostasis in the midgut after a blood meal is crucial, not least because of the pivotal role of ROS in gut immunity. In the mosquito *Ae. aegypti*, a blood meal leads, perhaps counterintuitively at first, to a dramatic decrease in ROS levels in the midgut ([@B147]). This decrease is due to a heme-mediated activation of protein kinase C (PKC) which leads to lowered ROS generation in midgut epithelial cells. The authors interpret this as an adaptation to compensate for the pro-oxidant blood meal and to avoid heme-mediated oxidative stress, thus maintaining redox homeostasis. However, lowered ROS levels in the gut are probably associated with decreased resistance to infection and increased mortality ([@B147]). Interestingly, overall ROS levels do not change significantly after a blood meal in *Ae. polynesiensis* which, unlike *Ae. aegypti*, is naturally infected with *Wolbachia* ([@B2]). In a coevolutionary process, the host might have abolished the PKC-mediated decrease in ROS levels in the gut because of *Wolbachia*-induced antioxidant production (immune interference). Therefore, it is reasonable to assume that *Wolbachia* help in maintaining redox homeostasis in this evolved symbiosis ([@B59]). Moreover, when *Ae. polynesiensis* is fed sucrose only, there is no significant difference between ROS levels of infected and cured mosquitoes, and these ROS levels are lower than that of artificially infected mosquitoes ([@B2]). A possible explanation for this finding is that, due to coevolution between *Ae. polynesiensis* and its symbiont, the mosquito has reduced ROS production to mitigate oxidative stress (immune tolerance). Evolution of immune tolerance might therefore also be at play in the *Wolbachia*--*Ae. polynesiensis* symbiosis ([@B137]).

In the spider mite *T. urticae*, *Wolbachia* infection is associated with the enrichment of gene sets related to oxidoreductase activity ([@B223]). Oxidoreductases are known to produce ROS ([@B160]; [@B48]), but also to control redox homeostasis ([@B131]). Moreover, *Wolbachia* encodes an oxidoreductase (*α*-DsbA1) which, due to its low redox potential, might have antioxidant properties ([@B103]). Therefore, it is conceivable that *Wolbachia* directly or indirectly regulate redox homeostasis and thus maintain their association with *T. urticae*.

We do not want to conceal that there also are some findings from natural *Wolbachia*--host associations that are more difficult to reconcile with the above hypothesis, or at least more difficult to interpret. In the pill bug *Armadillidium vulgare*, some antioxidants (thioredoxin, ferritin) are upregulated in the ovaries of infected individuals (as compared to uninfected ones), while others (Prx, glutathione peroxidase) are downregulated ([@B29]). Perhaps, upregulation of some antioxidants is just a compensation for the downregulation of others, or *vice versa*. It is unclear, however, what is induced by the host and what by the bacteria. In the parasitoid wasp *Asobara tabida*, the expression of several antioxidant genes (oxidoreductase, glutathione peroxidase, ferritin) is downregulated in infected ovaries, compared to ovaries from cured wasps ([@B97]). At first, this seems to contradict our hypothesis. However, the *Wolbachia--Asobara tabida* association is a special case because here, the host is strictly dependent on its symbiont ([@B226]). Females cured of infection fail to produce oocytes, due to extensive apoptosis in egg chambers ([@B152]). The authors suggest a co-evolutionary scenario where the wasp responds to infection with apoptosis, which is then suppressed by *Wolbachia*. *Asobara tabida* in turn compensates for suppression by further increasing the apoptotic signal because it is essential for proper egg development ([@B152]). There is good empirical support for this scenario. First, *Wolbachia* are probably able to directly or indirectly suppress apoptosis. Suppression of apoptosis might be due to *Wolbachia* interfering with host iron metabolism and oxidative stress control ([@B98]; [@B59]; [@B226]). Moreover, it is known that ROS can act as initiators and mediators of apoptosis ([@B186]; [@B41]). Therefore, downregulation of antioxidant genes could be a host measure to further increase the apoptotic signal. In sum, the dependence of *Asobara tabida* on *Wolbachia* might well be a consequence of the evolution of tolerance following the disruption of redox homeostasis ([@B137]; [@B226]).

Lastly, we point to the fact that all cases that are compatible with the hypothesis involve CI-inducing *Wolbachia* (*Ae. albopictus*, *Ae. polynesiensis*, *D. melanogaster*, *D. simulans*, *T. urticae*). In contrast, *Armadillidium vulgare* is naturally infected with feminizing *Wolbachia*, and the strain that *Asobara tabida* depends on for oogenesis does not exhibit any reproductive phenotype (although the possibility that it induces CI remains untested). Therefore, one could think of a mechanistic connection between the host oxidative environment and the CI phenotype. Indeed, [@B17] showed that total SOD levels are significantly higher in testes of *D. simulans* males infected with CI-*Wolbachia* than in testes of cured males. Taking this as evidence of higher oxidative stress in infected testes, the authors presumed that disruption of redox homeostasis caused DNA damage in spermatocytes of infected males. Strikingly, DNA damage is significantly higher in infected compared to uninfected spermatocytes and might be a contributing factor to the sperm modification characteristic of CI ([@B17]). For example, DNA damage in spermatocytes could, after fertilization, lead to DNA replication defects in the male pronucleus as observed in CI crosses in *D. simulans* ([@B107]).

*Wolbachia* and Anti-Pathogenic Effects
---------------------------------------

The possibility of *Wolbachia*-induced host protection has recently spurred intense research efforts. Taking a slightly critical stance, we have proposed to distinguish protection from mere anti-pathogenic effects ([@B226]). Following our definition, *Wolbachia* are said to induce an antipathogenic effect whenever infection increases host resistance and/or tolerance to pathogens. However, an antipathogenic effect should only be classified as protection if it is associated with a fitness benefit to the host. Since so far only a few studies have found evidence for *Wolbachia*-mediated protection in the field ([@B71]; [@B198]; [@B149]; [@B221]), we here focus on antipathogenic effects.

The molecular mechanisms underlying *Wolbachia*-mediated antipathogenic effects are still unclear ([@B161]; [@B88]; [@B226]). Antiviral effects seem to be more frequent than antibacterial effects. Moreover, the strength of the antipathogenic effect is positively correlated to *Wolbachia* density. But how is the insect immune system involved? Antipathogenic effects are frequently observed when *Wolbachia* are transfected into hosts that are either naturally uninfected or infected with a different strain. As outlined above, in such cases, infection induces the upregulation of host immune genes, in particular genes involved in the Toll and Imd pathway, leading to the generation of AMPs. Such immune upregulation of Toll/Imd pathway genes is assumed to underlie antipathogenic effects in novel hosts, especially antiviral effects in mosquitoes ([@B213], [@B90], [@B89]; [@B138]; [@B12]; [@B151]). However, other studies have shown that, both in native and novel hosts, genes involved in the Toll or Imd pathway are not required for *Wolbachia*-mediated antipathogenic effects ([@B211]; [@B163], [@B162]; [@B32]; [@B51]; [@B122]). Therefore, upregulation of immune genes involved in the Toll/Imd pathways cannot be the universal explanation for *Wolbachia*-induced antipathogenic effects, let alone for host protection in the field ([@B226]).

The possible role of ROS in *Wolbachia*-induced antipathogenic effects has been less intensively studied than that of AMPs. The mosquito *Ae. aegypti* is naturally not infected with *Wolbachia*, but transfection of the *w*AlbB strain into *Ae. aegypti* inhibits replication of Dengue virus ([@B12]). It could be shown that transfection induces NOX- and DUOX-dependent ROS generation. Increased ROS levels activate the Toll pathway, which then mediates the production of antioxidants and AMPs such as defensin and cecropin. These AMPs are involved in inhibiting the proliferation of Dengue virus in *Wolbachia*-transfected mosquitoes ([@B151]). In transfected *Ae. albopictus* mosquitoes, by contrast, ROS-mediated immune activation is probably not involved in the antiviral effect of *Wolbachia* ([@B135]). A recent study analyzed the relationship between ROS levels and antiviral effects in naturally infected *Drosophila* strains ([@B210]). The study included *Wolbachia* strains that were known to either have an antipathogenic effect ("protective" strains) or not ("non-protective" strains). In flies that harbor a protective strain, ROS levels are significantly higher than in flies cured of the protective strain. By contrast, presence of the non-protective strain has no significant effect on ROS levels relative to cured flies. These findings suggest that ROS levels are increased in *Drosophila* naturally infected with protective *Wolbachia* strains. Moreover, elevated ROS levels confer a survival advantage against mortality induced by Drosophila C virus (DCV; [@B210]). The anti-DCV effect is probably not mediated by the Toll pathway because *Wolbachia*-induced antiviral effects were shown to be independent of this pathway in *Drosophila* for both Dengue virus and DCV ([@B162]; [@B51]). Interestingly, the ROS-mediated survival advantage is not associated with reduced virus accumulation, pointing to increased tolerance rather than resistance ([@B210]). Tolerance mechanisms have been shown to be at play in other coevolved *Wolbachia*--host systems where the symbionts induce antipathogenic effects ([@B198]; [@B149]; [@B222]). In sum, the possibility that a *Wolbachia*-induced ROS-based immune response is involved in antipathogenic effects constitutes a promising topic for future research.

*Wolbachia*, ROS, Life-History Trade-Offs, and Mitohormesis
-----------------------------------------------------------

Organisms cannot maximize all fitness-relevant traits at once. Rather, they face the challenge to optimally allocate limited resources among those traits. Hence, the evolution of fitness-related traits is constrained by the existence of trade-offs between them. These trade-offs play a fundamental role in life-history theory ([@B191]). Along these lines, immune defense can be viewed as a life-history trait as well, and trade-offs between immunity and other fitness-related traits ("costs of immunity") have been gaining increasing attention among evolutionary ecologists ([@B185]; [@B228]; [@B180]; [@B182]; [@B129]).

Much effort has been made to elucidate the physiological mechanisms underlying life-history trade-offs. Given their antagonistic and pleiotropic effects, ROS have recently been proposed as central players in the occurrence of such trade-offs ([@B43]; [@B136]; [@B132]; [@B84]; but see [@B189]). In particular, because of their pivotal role in innate immunity on the one hand and in oxidative stress on the other hand, ROS may be a key factor underlying the trade-off between immunity and other life-history traits such as fecundity and longevity ([@B137]).

Building upon these ideas and on the intimate connections between *Wolbachia* and the host oxidative environment, one may speculate that *Wolbachia* are involved in the occurrence of the trade-off between immunity and other life-history traits, and that this involvement is, at least in part, mediated by ROS. There is some evidence for this hypothesis. [@B159] studied the effect of transfected *Wolbachia* strains on immunity and reproduction in the woodlouse *Porcellio dilatatus*. They found a clear trade-off between both life-history traits: the *w*Con strain increases investment in immune parameters but reduces reproductive investment (whereas the *w*Dil strain has the converse effect). However, the tested immune parameters (such as hemocyte density or phagocytosis activity) do not allow to draw a conclusion on whether ROS are involved in the trade-off. In *D. simulans*, there is a similar trade-off between *Wolbachia*-induced antiviral protection and egg hatch rates, female fecundity, and male fertility ([@B123]). Another example of *Wolbachia*-associated costs of immunity involves the trade-off between immunity and longevity. *Wolbachia* strains that induce strong antiviral effects in *D. melanogaster* (so-called *w*MelCS-like strains) often shorten the host lifespan ([@B31]). Strikingly, the *w*MelCS strain was recently shown to increase ROS concentration twofold relative to a *Wolbachia*-free control ([@B210]). Therefore, it is possible that elevated ROS levels are responsible not only for the antiviral effect, but also for the shortened lifespan.

The impact of ROS and oxidative stress on longevity and aging has been debated for more than half a century. The seminal "free radical theory of aging" states that the production of mitochondrial ROS is the major cause of aging ([@B68], [@B69]; [@B4]). However, findings are accumulating that seem to be incompatible with this theory ([@B108]; [@B190]; [@B196]; but see [@B95]). In particular, recent evidence suggests that moderately increased formation of ROS in the mitochondria causes higher stress resistance and eventually extends life span, a process that has been termed mitochondrial hormesis (mitohormesis; [@B167]; [@B219]). In general, hormesis is defined as any adaptive response exhibiting a biphasic dose response ([@B22]). Usually, such biphasic dose responses are characterized by a beneficial effect at low doses and a harmful effect at higher doses. In a narrower, and recently more frequently used, sense, hormesis describes the phenomenon that a mild, sublethal stress causes an adaptive response that protects against larger subsequent stresses. The latter meaning of the term has been named "stress-response hormesis" ([@B57]). Mitohormesis represents a form of stress-response hormesis: Mild mitochondrial stress increases ROS formation which induces stress response mechanisms (such as antioxidant production), ultimately causing a long-term reduction of oxidative stress. Mitohormesis thus involves both an increase in mitochondrial ROS and a subsequent antioxidant response, and the notion of a mitohormetic pathway is tightly associated with the role of ROS as important signaling molecules ([@B67]; [@B52]). Several recent studies have shown this mitohormetic pathway to be at work in promoting survival and longevity ([@B92]; [@B27]; [@B183]; [@B220]; [@B139]; [@B36]). Given that *Wolbachia* are known to promote longevity in several hosts ([@B226]), it is tempting to speculate that they do so by triggering the mitohormetic pathway. More generally, the mitohormetic pathway is strongly reminiscent of the hypothesized "immune interference" phenotype of *Wolbachia* in native hosts (in which the symbionts not only induce a ROS-based immune response, but also the expression of antioxidant genes; Figure [1F](#F1){ref-type="fig"}). Taken together, some fitness-enhancing effects of native *Wolbachia* (e.g., promoting longevity, maintaining redox homeostasis) might be attributable to mitohormesis.

With regard to the impact of ROS on fitness-related traits, the trade-off approach and the mitohormesis approach might appear to come to quite different conclusions. For example, ROS are assumed to shorten lifespan under the former approach and to extend lifespan under the latter. More generally, the trade-off approach states that *Wolbachia* (via ROS) have a positive effect on some fitness parameters and a negative effect on others, whereas the mitohormesis approach emphasizes the positive fitness effect of *Wolbachia*-induced mitochondrial ROS formation. However, hormesis itself is assumed to trade off with at least some fitness-related traits because a positive hormetic effect on overall fitness would be at odds with life-history theory ([@B54]). Accordingly, a recent study finds that pathogen challenge in *Drosophila* enhances not only survival and fecundity, but also susceptibility to infection, suggesting a trade-off between hormesis and immunity ([@B126]). Therefore, both approaches involve some form of trade-off and thus are not mutually exclusive.

Conclusion
==========

Reactive oxygen species represent a double-edged sword: They are known to cause oxidative stress and damage cellular macromolecules. However, given their cytotoxic nature, ROS also are efficient microbicidal effectors which play a crucial role in the insect immune system. Due to this antagonistic pleiotropy, ROS probably underlie evolutionary trade-offs between immunity and other life-history traits such as fecundity and longevity. *Wolbachia* are widespread intracellular bacteria famous for their ability to modulate exactly these fitness-related host traits in intriguing ways. At the same time, they must be able to cope with the host immune system in order to invade and persist in their insect hosts. Therefore, the host oxidative environment represents a promising area to elucidate the mechanisms of *Wolbachia*--host interactions.

In newly infected hosts, *Wolbachia* usually trigger an immune response which is aimed at eliminating the infection. In co-evolved associations, by contrast, either the host has curbed the immune response when it pays to do so, or the symbionts have evolved ways to resist the host immune response. They do so by adopting a variety of strategies, including immune evasion by stealth, suppression, and interference. We propose that in co-evolved symbioses, *Wolbachia* frequently make use of the latter strategy in that they not only induce a ROS-based immune response but also an antioxidant response. Thereby the bacteria are involved in maintaining redox homeostasis. Interference with the host oxidative environment might also underlie other mutualistic phenotypes of *Wolbachia* such as enhancing host defense or promoting longevity, possibly via mitohormetic effects. On the other hand, *Wolbachia*-induced ROS formation might be involved in parasitic phenotypes such as cytoplasmic incompatibility. Taken together, *Wolbachia*'s impact on the host oxidative environment probably contributed to their tremendous success and opens up exciting avenues for future research.
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